Suppr超能文献

全基因组 RNA 干扰筛选鉴定出半胱天冬酶 4 是肿瘤坏死因子-α信号通路所必需的一个因素。

A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling.

机构信息

German Cancer Research Center (DKFZ), Division of Signaling and Functional Genomics, and Heidelberg University, Department of Cell and Molecular Biology, Medical Faculty Mannheim, Heidelberg, Germany.

出版信息

Mol Cell Biol. 2012 Sep;32(17):3372-81. doi: 10.1128/MCB.06739-11. Epub 2012 Jun 25.

Abstract

Tumor necrosis factor alpha (TNF-α) is a potent inflammatory cytokine secreted upon cellular stress as well as immunological stimuli and is implicated in the pathology of inflammatory diseases and cancer. The therapeutic potential of modifying TNF-α pathway activity has been realized in several diseases, and antagonists of TNF-α have reached clinical applications. While much progress in the understanding of signaling downstream of the TNF-α receptor complex has been made, the compendium of factors required for signal transduction is still not complete. In order to find novel regulators of proinflammatory signaling induced by TNF-α, we conducted a genome-wide small interfering RNA screen in human cells. We identified several new candidate modulators of TNF-α signaling, which were confirmed in independent experiments. Specifically, we show that caspase 4 is required for the induction of NF-κB activity, while it appears to be dispensable for the activation of the Jun N-terminal protein kinase signaling branch. Taken together, our experiments identify caspase 4 as a novel regulator of TNF-α-induced NF-κB signaling that is required for the activation of IκB kinase. We further provide the genome-wide RNA interference data set as a compendium in a format compliant with minimum information about an interfering RNA experiment (MAIRE).

摘要

肿瘤坏死因子-α(TNF-α)是一种在细胞应激以及免疫刺激时分泌的强效炎症细胞因子,与炎症性疾病和癌症的发病机制有关。通过改变 TNF-α 通路活性的治疗潜力已在多种疾病中得到证实,TNF-α 的拮抗剂已达到临床应用。尽管已经对 TNF-α 受体复合物下游的信号转导进行了大量研究,但信号转导所需的因素仍不完整。为了寻找 TNF-α 诱导的促炎信号的新调节因子,我们在人类细胞中进行了全基因组小干扰 RNA 筛选。我们鉴定了几种新的 TNF-α 信号转导候选调节剂,这些调节剂在独立实验中得到了验证。具体来说,我们发现半胱天冬酶 4 是诱导 NF-κB 活性所必需的,而它似乎对于 Jun N-末端蛋白激酶信号分支的激活是可有可无的。总之,我们的实验将半胱天冬酶 4 鉴定为一种新型 TNF-α 诱导的 NF-κB 信号转导调节剂,它对于 IκB 激酶的激活是必需的。我们进一步提供了符合小干扰 RNA 实验最小信息(MAIRE)格式的全基因组 RNA 干扰数据集。

相似文献

2
Protein Kinase-Mediated Decision Between the Life and Death.蛋白激酶介导的生死抉择。
Adv Exp Med Biol. 2021;1275:1-33. doi: 10.1007/978-3-030-49844-3_1.

引用本文的文献

8
ERAD-dependent control of the Wnt secretory factor Evi.ERAD 依赖性调控 Wnt 分泌因子 Evi。
EMBO J. 2018 Feb 15;37(4). doi: 10.15252/embj.201797311. Epub 2018 Jan 29.

本文引用的文献

8
Inflammatory caspases in innate immunity and inflammation.先天免疫和炎症中的炎性半胱天冬酶。
J Innate Immun. 2010;2(3):228-37. doi: 10.1159/000283688. Epub 2010 Feb 10.
9
The inflammasomes.炎症小体。
Cell. 2010 Mar 19;140(6):821-32. doi: 10.1016/j.cell.2010.01.040.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验